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I. INTRODUCTION 
The observation that individuals who are suffering from various 
nutritional deficiencies are more susceptible to infectious diseases has 
been made frequently by clinicians. Observations made on swine indicate 
that the young anemic pig is much less able to withstand disease out­
breaks than those which are not anemic. The period of greatest anemia in 
the young pig is very closely correlated with the age at which it is 
believed that most animals are poor antibody producers and occurs at a 
time when the residual passive immunity, which the piglet gets from 
colostrum, is low. 
It is during this period that the baby pig appears to offer the 
least resistance to infection. During this period of time organisms that 
are ordinarily considered to be nonpathogenic or only mildly pathogenic 
may suddenly overwhelm the baby pig. The combination of anemia and 
infections frequently results in great economic loss through death and 
through "stunted" or "poor doing" pigs. The nonanemic pig fights off 
these infections, many times not even showing clinical signs of the 
disease process. Since the amount of passive inmunity which each pig 
within a litter receives at birth is approximately equal, it has been 
assumed that the difference in resistance to infection is due to the 
individual's ability to produce antibodies. 
Various studies have been made concerning antibody production in the 
presence of nutritional deficiencies of several species. However, no 
investigation could be found which was concerned with the production of 
antibodies in the presence of iron-deficiency anemia in the young pig. 
The study reported herein was conceived and initiated to investigate 
the effects of iron on the production of antibody in the young pig, the 
effects of anemia, and the effects of iron deficiency without anemia on 
antibody production. 
To produce iron deficiency without anemia the iron chelating agent, 
desferrioxamine, was used. Since desferrioxamine has been used as an 
iron chelating agent to treat iron toxicity in man for only a very short 
period of time, and no work had been done with this compound in the pig, 
it was necessary to study the effects of desferrioxamine on the pig. Data 
showing the effect of desferrioxamine on urinary iron content, serum iron, 
unbound transferrin, serum iron-binding capacity, erythrocyte number, 
hemoglobin values, packed cell volume, erythrocyte sedimentation rate, 
body weight, and leukocyte number are included. In addition, observa­
tions were made to determine if desferrioxamine had any toxic effect at 
the dosage levels used. 
Hie antigen which was used in this study was equine ferritin. This 
selection was made because a reliable quantitative determination has 
been developed to determine antibody levels to this antigen. It was also 
selected because the pigs would not have had a chance of natural expo­
sure to the antigen as they would have had if a pathogenic microorganism 
such as Escherichia coli were used. 
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II. REVIEW OF LITERATURE 
A. General Considerations 
The terms "natural resistance" and "natural immunity" are used to 
designate a state in which a host resists damage by a microbial pathogen 
even if the organism is present in the tissues or on the body surface. 
This innate resistance of the host is genetically determined. In 
contrast to acquired immunity, it is not dependent on previous exposure 
of the host to the pathogen. Acquired immunity has received much more 
attention and has been studied to a much greater degree than natural 
resistance. From this study the scientific discipline, immunology, has 
evolved. Artificial immunization has proven to be a highly beneficial 
and practical procedure to both animals and man in those cases where it 
is effective. Yet, comparatively little knowledge is available per­
taining to the role of nutrients in antibody production. 
B. Antibody Production 
The term "immune response" is used to describe the reaction of the 
body to any antigenic substance. Generally speaking any foreign 
proteinaceous substance can be used to elicit an immune response in any 
animal. More specifically an antigen is a high molecular weight 
substance or complex, usually protein or protein-polysaccharide complex 
and occasionally polysaccharide in nature, which, when foreign to the 
blood stream of an animal, on gaining access to the tissues of such an 
animal stimulates the formation of specific antibody and reacts specif­
ically in vivo or vitro with its homologous antibody. 
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1. Swine 
Although a considerable amount of work in the area of immunology has 
been done with swine from birth through eight weeks of age, a search of 
the literature showed no work done on the effects of iron-deficiency 
anemia on antibody production by pigs of this age. 
In the pig there is very little placental transfer of antibodies; 
therefore, the dietary intake of proteins by the baby pig is extremely 
important because they confer a passive immunity due to the gamma 
globulins which they contain. 
Perrin (1955) found that at the time of parturition the protein 
content of sow's colostrum may be as high as 63% of the total dry matter, 
but this drops very rapidly during the next three days to a level of 27%. 
Furthermore, it is known that at the time of parturition the proteins of 
colostrum are composed of approximately 70% albumins and globulins, but 
by three days postpartum the protein content has changed so that about 
60% of the protein is in the form of casein according to the work done by 
Travnicek in 1960 which is cited by Agricultural Research Council-"(1967). 
The protein of colostrum contains more threonine, valine, leucine, and 
phenylalanine than that of milk (Beacom and Bowland, 1951), and threo­
nine is known to occur in high proportion in immune globulins (Smith 
and Green, 1947). 
Many workers have found that during the first 24-36 hours after 
birth the pig is able to absorb complete proteins from the intestine, 
and it is during this time that the passive iimnunity, due to absorption 
of antibodies, normally is conferred upon the baby pig (Asplund et al. 
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1962, Brambell, 1958; Brown e£ al^. 1961; Bruner ejt £l. 1949; Lecce and 
Matrone, 1960; Lecce et^ £1.. 1961; Miller e£ a^. 19bZ; and Speer et. ïi-
1959). Furthermore, Laskowski al.. (1957) postulated that the high 
level of trypsin inhibitor, found in the colostrum of sows during the 
first few days following parturition, protects the antibodies from 
digestion by trypsin, thus allowing absorption of Che complete protein. 
Payne and Miarsh (1962) found that by three days of age the ability 
to absorb complete proteins is almost lost in pigs which have been fed 
since birth. They also found that if pigs were obtained by hysterectomy 
and then either starved or given only water for the first four days, 
they still retained the ability to absorb gamma globulins after this 
period of time. 
As a result of the absorption of complete proteins, the serum protein 
pattern of the pig receiving colostrum changes rapidly during the first 
few days of life. Nordbring and Olsson (1958a and 1958b) found serum 
collected from the umbilical cord to be very low in total protein, high 
in nonprotein nitrogen, and devoid of antibodies. They also found that 
the ingestion of colostrum resulted in a rapid appearance of antibodies 
in the serum of the pig along with an increased total protein and a 
decrease in nonprotein nitrogen. Other work confirmed the absence or 
very low levels of gamma globulins in the serum at birth followed by a 
rapid rise which occurs after the consumption of colostrum (Lecce and 
Matrone, 1960; McCance and Widdowson, 1956; McCance and WidSowson, 1959; 
Miller et a£, 1961; Rutqvist, 195S;—and Wllber et al. 1959). 
After the initial rise following the ingestion of colostrum, the 
level of serum antibodies from this source steadily falls. Meade (1956) 
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found that*the level of absorbed antibodies fell to an immeasurable level 
by 17 days of age, but other workers found that the level is low but 
measurable until six to eight weeks of age (Brown, 1959; Young and 
Underdahl, 1949; and Young and Underdahl, 1950). 
The foregoing review of the literature indicates that baby pigs are 
quite able to absorb antibodies from the digestive tract and thereby get 
passive immunity and protection from disease conditions during the early 
stages of life. This work generally agrees, and the reports are not con­
flicting. On the other hand evidence on the ability of the young pig to 
synthesize its own antibodies at an early age Is very conflicting. 
Harmon e£ (1959) and Olsson (1959a) found that suckling pigs were 
able to develop antibodies by three weeks of age. This same finding was 
reported by Rice and L'Ecuyen (1963) and Sterzl et al. (1960), but they 
were working with pigs that were deprived of colostrum. Bauriedel e^ al. 
(1954), Hoerleln (1957), Hoerleln (1952), and Staub and Boguth (1956) 
found that pigs deprived of colostrum did not produce antibodies until 
they were from six to eight weeks of age. 
Segre and Kaeberle (1962a) confirmed the work of Hoerleln showing 
that colostrum deprived pigs were poorer antibody producers than 
colostrum-fed pigs of the same age. They also published (1962b) work 
indicating that prior contact with antibody for the antigen being tested 
enhanced the ability of the pig to produce antibody. In 1964, Segre and 
Myers published material further confirming this hypothesis. Their 
results were consistent with the hypothesis that natural, nonantigen-
induced antibodies are required for antibody formation and that such 
antibodies are formed in the young pig as a part of the physiologic 
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processes leading to immunologic maturity. 
This work is in direct conflict with work pubiisneo oy Kim e£ al. 
(1966). Kim et al. (1966) found that colostrum-deprived pigs which were 
derived by cesarean section three to five days before term were able to 
develop antibodies by two days of age if they were injected within five 
hours of delivery. Another significant finding of this group was that 
pigs injected at five hours of age and kept colostrum-free gave a greater 
immunologie response than animals previously exposed to antigens or 
immunoglobulins. Kim e£ a]^. (1967) found that by six days colostrum-
deprived, germ-free piglets were able to synthesize significant amounts 
of 19S. gamma globulin, but it was not until 24 days of age that all 
known classes of immunoglobulins were evident. 
Brown et. al» (1961) found that colostrum-acquired antibodies were 
detectable in the serum of pigs for 6 weeks after birth but were low 
after three weeks. They also found that both weaned and unweaned pigs 
were able to produce antibodies by three weeks of age, but these were not 
fully protective until four to five weeks of age. Other workers have 
found very low levels of ganma globulin in the serum of pigs at four to 
five weeks of age followed by a gradual rise indicating synthesis by the 
pig itself (Nordbring and Olsson, 1958a; Nordbring and Olsson, 1958b; 
Rutqvist, 1958; and Staub and Boguth, 1956). 
The review of the literature indicates that the pig is in a 
critical period of susceptibility to infection from the third to the 
fifth week of life because this is a period when the effects of passive 
immunity are at a minimum, and the ability to develop antibodies is 
questionable- This period of time also correlates very closely with the 
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period of time when iron-deficiency anemia of the pig is most common. 
The antibody response of swine has been studied by several workers, 
but their efforts have been directed toward factors other than anemia 
which affect the response, and a small amount of work has been done on 
characterizing the response itseit. Hogle (1967) worked with eight pigs 
which were five weeks old and studied the antibody response to Escherichia 
coli and to equine ferritin in these pigs. He found that antibodies 
could be detected by four days after injection with Escherichia coli but 
not by three days after injection. His first serum samples for equine 
ferritin antibody studies were collected at four days after injection at 
which time antibodies could be detected. Kim e_t (1966) found that 
piglets injected with purified actinophage MSP-2 within five hours after 
hysterectomy showed no antibody titer at 36 hours of age but did at 48 
hours of age. They also found that if injections containing more than 
one antigen were given, antigenic competition occurred so that the amount 
of antibody produced to the test antigen was lowered. 
2. Other species 
Reports on antibody production by young animals are numerous, but 
most work has been done on the human infant. Sako (1947) studied the 
inmune response to pertussis vaccine in young infants. He observed that 
following inmunization the level of agglutinin to pertussis reached a 
plateau after two to four months and remained at that level for approx­
imately three years. Until this time it was believed that young infants 
were unable to produce antibodies to pertussis. It should be mentioned 
that Sako (1947) used an alum precipitated antigen which gives a 
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prolonged antigenic stimulation, and this may have affected his results. 
Sauer e_c (1^44^, sake e_c a_i. (1945), Bell (154S), cirid 
Tucker (1950), and di Sant Agnese (1950) worked with multiple antigens 
and gave repeated injections to young infants. Their findings were very 
similar. That is, they all found that a large percentage of very young 
infants injected produced antibodies. Infants used in these studies 
ranged from one to 13 weeks of age. di Sant Agnese (1950) also repeated 
his study on older infants. He found that if infants six months of age 
or older were immunized using the same routine as for younger infants, 
the antibody production was much better. He found that for diphtheria 
and pertussis, the antibody level was twice as high in the older infants 
in a comparable length of time while the tetanus antitoxin production was 
very similar for the two groups. 
Cooke (1948), Butler et al. (1950), and Barr al. (1954) found that 
infants from one to 14 weeks of age showed no significant difference in 
ability to produce tetanus antitoxin. They also found that this was not 
true ^ en diphtheria toxoid was used as the antigen. However, when they 
separated these infants into groups having presence or absence of maternal 
diphtheria antitoxin, they found that those having an absence of anti­
toxin responded well. Thus, they confirmed the work of Sauer et. 
(1944), Sako e£ (1945), Bell (1948), Sauer and Tucker (1950), and 
di Sant Agnese (1950). 
Osborn et (1952) substantiated this work by comparing the abil­
ity of infants of different ages to produce antitoxin to diphtheria 
toxoid. They showed that infants at two weeks of age were poorer anti­
toxin producers than infants at one month of age, while infants at one 
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month of age were poorer than those at two months of age. However, they 
could show no signitxcanc axtterence becwccu lufarits ever tvc cczthz cf 
age. 
Greenberg and Fleming (1950) were concerned with the effect of 
"inherited" antibody on antibody production. They found that "inherited" 
antibody had some effect in depressing the response to diphtheria toxoid 
but not great enough to prevent satisfactory immunization of infants. 
Data collected one year after the infants were immunized (Greenberg ejt al. 
1954) showed no difference in the antitoxin level. They concluded that 
"inherited" antibodies did not prevent a satisfactory response to an 
antigen, but simply delayed it. This same finding had been reported 
earlier by Vahlquist £t (1948) and subsequently by Osborn e£ al. 
(1952). Vahlquist and Nordbring (1952) measured antibody response in 
premature infants and concluded that it did not differ from that of full-
term infants. This work was confirmed by Dancis e^ a^. (1953). 
Freund (1930) immunized rabbits at one to two days of age with 
Bacillus typhosa and checked for levels of agglutinins five to six days 
later. He found low but detectable levels. The same was true for 
rabbits which he immunized with sheep erythrocytes. Because the levels 
of antibody produced by these young rabbits were low, Freund (1930) 
concluded that young animals were very poor antibody producers. 
Baumgartner (1934a, 1934b, and 1937) reached the same conclusion. 
Freund (1927) showed that young guinea pigs gave a slight immune 
response to Bacillus tuberculosis. Gross lesions of tuberculosis could 
be demonstrated in these guinea pigs, yet the tuberculin skin reaction 
was very slight, while the dams of these same guinea pigs treated in the 
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same way gave a marked reaction to tuberculin. 
Famulener (i9iZ) round tnac only a slighc innaunc ba 
elicited in young goats when sheep erythrocytes were injected subcu-
taneously at birth and at ten and 18 days of age. This work shows that 
the response on the part of the young goat is similar to other species 
studied. 
Overman (1954a and 1954b) studied the immune response of suckling 
mice to mumps virus. He found no detectable antibody production in mice 
under five days of age, a transitory response in mice from five to seven 
days old, and a response comparable to adult mice was seen in mice over 
14 days old. His work again showed that young animals are not as well 
equipped to produce antibodies as older animals are. 
Swartzendruber et al. (1961) found that if they removed the majority 
of the lymphoid tissue of the mouse, they saw a markedly reduced anti­
body response to sheep erythrocytes. This finding would be consistent 
with the theory that the thymic cells which lodge in the lymph nodes, 
spleen, bone marrow, and other antibody producing tissues are responsi­
ble for antibody production (Guyton, 1966). Hall and Morris (1963) gave 
further support for this work. They found that antibody levels in­
creased in lymph plasma and in cells leaving the lymph nodes during the 
immune responses following the injection of antigens. This work was 
done on the sheep popliteal lymph node. 
C. Effects of Nutrients on Antibody Production 
Much attention has been directed toward the possibility of a rela­
tionship between nutritive state and resistance to infection. Unfor­
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tunately, much of this work was done on man and animals which were 
affected by a general scace of mainucrii.iua, anJ as â result, the dztz 
collected do not illuminate the role of any one nutrient in the immune 
response. Animal experimentation has been done where one nutrient was 
studied, but the results are highly variable from one investigation to 
another, and, therefore, it is difficult to draw conclusions from the 
reports which appear in the literature. It is possible that these 
seemingly contradictory findings may be explained by the dosage, type, 
and route of administration of the antigen. Methods of quantitating the 
antibody response, species, general health of the animal used, and 
probably the degree and specificity of the deficiency state produced 
contribute to the antibody response observed. 
Since inanition frequently accompanies the deficiencies under con­
sideration, it is extremely important (and also difficult) to determine 
whether the effects observed in the deficiency are actually due to the 
specific nutritional factor which is absent or restricted or to the non­
specific effects of caloric restriction. Because of this uncertainty 
positive results in this area must always be scrutinized carefully and 
should be repeated at graduated deficiency levels to see if positive 
results can be obtained before inanition sets in. 
1. Vitamins 
The assumption that animals suffering from nutritional deficiencies 
are more susceptible to disease conditions has been made for a long 
period of time, yet work to find out exactly why is not substantiated. 
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Werkman (1923a) worked with rats, rabbits, and pigeons which were 
fed rations lacking in vitamins A or B-complex. After a period of 
feeding these rations the animals showed "striking symptoms of dietary 
deficiency". They were then subjected to different treatments for the 
production of agglutinins, precipitins, hemolysins, and bacteriolysins. 
Non-deficient control animals received the same treatment. His findings 
were that rats and rabbits lacking vitamins A or B-complex showed no 
difference in their ability to produce agglutinins, precipitins, hemo­
lysins, or bacteriolysins. He also found that pigeons fed rations 
lacking in B-vitamins responded to the injection of antigen with the 
production of agglutinins. He concluded that the cataphylaxis seen in 
animals suffering from the lack of vitamins is not the result of the 
destruction or paralysis of the antibody forming mechanisms. 
Gill and Coombs (1964) state that a hypogammaglobulinemia associated 
with a pernicious anemia in man is not corrected by the administration of 
vitamin B12» while such treatment does correct the pernicious anemia. 
Werkman (1923b) found that rats, rabbits, and pigeons suffering 
from a pronounced vitamin deficiency showed a marked break in their re-
sistaAce to infection. Rats and rabbits lacking in vitamin A became less 
resistant to infection with Bacillus anthracis and an undefined pneumo-
coccus. This same susceptibility was seen in rats on a vitamin B-complex 
deficient diet, and the results were similar to those described under 
conditions of starvation. Pigeons fed a diet deficient in B-vitamins 
also showed an increased susceptibility to these same organisms. Werkman 
found that deficient rabbits, rats, and pigeons died when exposed to these 
microorganisms while control animals survived. The values given for 
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hematologic observations in this work indicate that the animals used 
were not anemic. 
Werkman (1923c) studied the effects of vitamin A and B deficiencies 
on phagocytic activity in rabbits and rats. He found that the phago­
cytic indexes of rats deficient in vitamin B-complex did not exhibit 
marked variation from control animals when they were determined in 
vitro. However, ^  vivo he found slightly greater indexes for non-
immunized controls than in nonimmunized animals suffering from vitamin 
deficiencies. These differences were small, and Werkman theorized that 
they were probably due to temperature differences since body temperatures 
are lowered during vitamin starvation. 
Pike and Brown (1959) confirmed and added to the work of Werkman 
(1923a,b,c) when they studied the effect of vitamins on phagocytic 
activity. They found that vitamin A palmitate, choline, cyanocobalamin, 
ascorbic acid, a-tocopherol, and naphthoquinone did not affect the phago­
cytic, Index of rats. 
Hill e^ al. (1962) reported on the interaction of mouse salmonel­
losis resistance factor with dietary protein and vitamin levels. They 
reported a difference in response seen with low levels of vitamins and 
proteins. Since they were dealing with low levels of both, it appears 
that the evidence from other works would indicate that the differences 
seen were probably due to low protein levels, only five percent of the 
diet, rather than to low levels of vitamins. 
In one study involving the chicken, Panda and Combs (1963) showed 
that diets deficient in vitamin A, pantothenic acid, or riboflavin gave 
significantly lower agglutinin responses to Salmonella pullorum antigen 
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than controls. This may be due to a species difference since these 
workers used the chicken, or it may be coincidence. Nevertheless, this 
work does not agree with other work in the literature as to the effects 
of vitamins on antibody production. 
2. Minerals 
A search of the literature produced no reports of research done on 
the effects of various minerals on the immune response. Work, however, 
has been done which indicates that certain minerals are necessary for 
certain types of resistance. Gushing and Campbell (1957) showed that 
magnesium and calcium are essential for certain antibody-antigen 
reactions involving complement. These minerals have not been shown to 
be essential in the formation of either the antibody or the complement 
but are essential before the reaction with complement will take place. 
Najjar (1958) reported that certain properdin-complement reactions 
required magnesium before they would take place. This agreed with pre­
vious work by Gushing and Campbell (1957). Although this work indicates 
that minerals are necessary for resistance to disease, it sheds no light 
on the role of these minerals in the formation or production of antibody. 
3. Proteins 
Although this thesis does not deal with the effects of proteins on 
the immune response, a few words about its effects seem to be appro­
priate. It has been shown many times that certain levels of dietary 
protein are essential for resistance to disease. 
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Hunter (1953), Rledal and Ackert (1951), and Smith (1955) demon­
strated that individuals fed adequate amounts of protein were more 
resistant to helminths than those which were maintained on deficient 
rations. This indicates that proteins are essential not only in resis­
tance to bacterial infections but also to parasitisms. 
The mouse has frequently been used as the experimental animal in 
studying the effects of proteins on the immune response. Dubos and 
Schaelder (1958 and 1959) showed that by increasing the level of casein 
in the diet, mice became more resistant to bacterial infections when 
challenge doses of bacteria were given. Ruchman (1946) showed essen­
tially the same thing to be true when he challenged mice with Western 
equine encephalomyelitis virus, and Ruebner and Miyai (1961) confirmed 
this work in their study of viral hepatitis in mice. 
Traka (1956) showed that increasing protein levels in the diet of 
the rat was beneficial to a point. If excessive levels of protein were 
fed, the susceptibility to Infection increased. This same observation 
was made in chicks for certain microorganisms but not for Escherichia 
coli (Boyd and Edwards, 1963; Hill and Garren, 1961; and Smith and Chubb, 
1957). There are many reports in the literature dealing with the effects 
of proteins or specific amino acids on antibody production. Unfortu­
nately, the deficiency which is necessary to get an interruption of anti­
body production usually must be severe enough to cause a cessation of 
all body processes which require proteins; therefore, this work sheds 
very little light on the actual role of proteins or amino acids in 
antibody production. 
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D. Iron Chelation 
The therapeutic use of chelating agents to rid the body of various 
minerals led to the hope that one might be found that had a high spec­
ificity for iron. Although some of the earlier developed chelating 
agents such as dimercaprol and ethylenediamine-tetra-acetate will remove 
some iron from the body, neither is quantitatively effective (Ohlsson 
et al. 1953 and Seven e^ 1954), Fahey e_t (1961) showed that 
diethylene-diamine-tetra-acetate, would remove significant amounts of 
iron from the body in iron-storage diseases. These drugs have the 
disadvantage of chelating many other minerals in addition to iron and, 
therefore, have not generally been very useful for the treatment of 
iron-storage diseases. In fact, these may actually chelate other miner­
als in preference to iron to such a degree that deficiency symptoms asso­
ciated with other minerals are precipitated. 
Within the last several years a new chemical compound has been 
introduced and is being studied as a possible agent to use for its iron 
chelating properties. This chemical has been given the generic name of 
"desferrioxamine" and is available under the trade name of "Desferal^". 
Desferrioxamine is commonly referred to in the literature by 
several names. The most commonly employed names are: deferoxamine, 
deferrioxamine, deferroxamine, and propionohydroxamic acid. 
Propionohydroxamic acid is a colorless, crystalline substance which 
at pH 7.0 - 7.25 reacts quantitatively and selectively with trivalent 
iron ions to form ferrioxamine (Figure 1), a red colored compound which 
^CIBA Pharmaceutical Company, Summit, New Jersey. 
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is readily soluble in water (Wohler, 1962 and Fielding, 1965). 
The biochemistry of desferrioxamine and ferrioxamine was outlined 
by Yunice (1968). Both compounds are poorly absorbed from the 
gastrointestinal tract; therefore, if significant amounts of either of 
the compounds are to enter the body, they must be given parenterally. 
Ferrioxamine in the body is confined to 20% of the total body volume, 
presumably to the extracellular fluid; whereas, desferrioxamine is 
distributed throughout 50% of the total body volume and, therefore, must 
penetrate the cell to some degree. Whether desferrioxamine can enter 
the cell, tie up iron, and leave as ferrioxamine is not known (Brown 
e£ a^. 1967). Yunice e_t £l• (1968) also state that ferrioxamine is not 
metabolized and is almost entirely excreted in the urine within five 
hours. In contrast, desferrioxamine has a biological half-life of 
about one hour and is metabolized. Metabolism occurs largely by deam-
ination of the free amino groups on the pentane with subsequent oxidation 
of the terminal carbon atom to form a carboxyl group. Deamination occurs 
more rapidly in the plasma than in tissues and probably involves a 
monamine oxidase (Yunice et al. 1968). 
Iron chelation occurs iji vivo, and ferrioxamine is excreted in the 
urine and in the feces (Gevirtz et £l. 1965). The specific affinity of 
desferrioxamine for iron led to the suggestion by Moeschlin (1962) that 
it could be used to treat hemochromatosis and other siderosis and to bind 
iron in treatment of acute iron poisoning in man. Subsequently, Moeschlin 
and Schnider (1963) reported favorable results in treating such cases 
with desferrioxamine. Keberle (1964) further suggested that desferriox­
amine could be used as a screening test for iron-storage diseases by 
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Figure 1. The chelation of iron by propionohydroxamic acid. 
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measuring the increase in urinary iron after the intramuscular injection 
of this compound. 
The source of iron chelated by desferrioxamine is exclusively non--
heme iron (Wohler, 1962), but the sites of chelation have not yet been 
determined (Brown e_t a^. 1967). Some degree of iron chelation from 
transferrin has been demonstrated (Wohler, 1962) in vitro studies, 
but from in vivo studies done by Hallbarg (1964) and Ventura (1964), it 
appears that this does not occur to any measurable extent. 
Keberle (1964) found that desferrioxamine removed iron to its 
maximum capacity from ferritin and hemosiderin, to some extent from 
transferrin, but not at all from hemoglobin after incubation with these 
compounds. He further reports that in addition to increasing urinary 
iron excretion, desferrioxamine blocks enteral absorption of iron. 
Bannerman and Malpas (1965) confirmed this finding. They found that the 
enteral uptake of iron by rats was decreased i*en desferrioxamine was 
given with oral iron, but desferrioxamine had no effect on the absorp­
tion of hemoglobin iron in iron-deficient rats. 
Brown £t al. (1967) conducted an extensive study in an attempt to 
find the site of action of desferrioxamine. They found that neither 
iron dextran nor hemoglobin deposited in the tissues was mobilized from 
storage depots in any significant amounts. They also found that 
desferrioxamine had very little effect on the absorption of iron from 
the gastrointestinal tract, not enough to account for the high fecal 
iron excretion found in some patients treated with desferrioxamine. 
Gevirtz e_t al. (1965) found that desferrioxamine administered paren 
terally increased both urinary and fecal excretion of iron suggesting 
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that the work done on urinary iron excretion alone does not give a 
complete picture of the value of desferrioxamine in the treatment of 
iron overloading. This work sheds some doubt on conclusions which might 
be drawn from data presented by Hwang and Brown (1964), Walsh et al. 
(1964), and Fairbanks et (1963), whose work dealt only with urinary 
iron excretion. 
Walsh £t £l. (1965) found that desferrioxamine could be used to 
differentiate patients with iron-storage diseases from normals. They 
also reported that the level of unsaturated transferrin is an important 
limiting factor in the ability of desferrioxamine to remove iron. This 
is in agreement with Keberle (1964), Ventura (1964), and Hallberg (1964), 
who found that desferrioxamine would remove litLle if any iron from 
transferrin. Walsh et. 2k' (1965) also observed that the maximum ex­
cretion of urinary iron occurs within six to 12 hours after the admin­
istration of desferrioxamine. In the same paper, they reported the effect 
of desferrioxamine on serum iron and iron binding capacity for a period 
of 24 hours following administration of desferrioxamine. They found 
that serum iron increased after desferrioxamine administration in all 
patients with iron retention diseases. The same was true for total iron 
binding capacity. In contrast, they found that the control patients' 
serum iron level decreased slightly, and this was associated with a rise 
in iron binding capacity. 
Hwang and Brown (1964) gave values for the amount of iron excreted 
in the urine in patients treated with desferrioxamine. In seven patients 
suffering from iron overload disease conditions, they found from 2.5 to 
24.1 mg. of iron per gram of desferrioxamine administered were excreted 
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in the urine within 24 hours after treatment. They also tested the drug 
in normal patients and in patients having iron-deficiency anemia. Urinary 
iron excretion was found to be increased in both groups although the 
increase was much lower in the anemic subjects. The increase in normal 
subjects was approximately 13-fold, the anemic group showed an increase 
of only three-fold, while the iron-overload subjects gave an increase of 
20-fold. Walsh ^  (1965) also reported values for urinary iron 
excretion, but their values were slightly different. They showed five--
fold increases for normal patients, but in patients with hemochromatosis 
they found an increase in the range of 50 to 100 times the levels 
obtained prior to treatment. 
Hwang and Brown (1964) also reported that toxicity following the 
use of desferrioxamine in the human is negligible. Their report is 
based on only clinical observations which showed no effects other than 
local soreness or occasional hematocysts at the site of injection. This 
agrees with observations made by most people using this drug clinically 
(Moeschlin and Schnider, 1963). 
Brueckner e£ al. (1967) observed that desferrioxamine given in large 
daily doses for prolonged periods of time resulted in irreversible 
opacities of the lens in dogs, cats, and rabbits. In addition to this 
they found a severe gastroenteritis accompanying the high dose of 
desferrioxamine. Dosages used were 500 mg./kg. in the dog and cat and 
one gram/kg. in the rat. 
Although many workers (Hwang and Brown, 1964; Wohler, 1962; and 
Moeschlin and Schnider, 1963) have found desferrioxamine to be quite 
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specific for iron chelation, Yunice £t al. (1968) studied the effect of 
a single daily intramuscular injection of 100 mg. per kg. of body weight 
in weanling rats for a period of one and four months. They examined the 
liver, kidneys, heart, lungs, spleen, pancreas, and brain by emmission 
spectrography for the following trace elements; iron, manganese, zinc, 
copper, molybdenum, lead, aluminum, and tin. They assayed other metals 
as well but found no change in them. Briefly, they showed that the 
hepatic iron was significantly decreased as was the renal iron, but the 
cardiac iron increased after four months of treatment. The four-month 
treatment also significantly decreased manganese in all tissues studied 
except the spleen, increased the zinc content of the kidneys, lungs, and 
brain, and increased cardiac copper and brain molybdenum levels. 
Desferrloxamine was also found to decrease aluminum content of the heart, 
lungs, pancreas, and brain and to decrease lead levels in all tissues 
studied. Prolonged treatment had no effect on tin levels in any of the 
tissues studied. It should also be noted that no clinical symptoms of 
deficiency or excess of any of these metals were produced. Work done 
by Moeschlin and Schnider (1963) showed no increase in excretion of 
trace metals other than iron in the urine. These findings are also 
reported by many other workers. This appears to conflict with the work 
of Yunice (1968) but might be explained by increased biliary or fecal 
excretion rather than by urinary excretion of these other metal complexes. 
Although the results with desferrloxamine in the treatment of 
chronic iron toxicity have been very promising, the best results to 
date have been reported in the treatment of acute toxicity (Henderson 
et al. 1963 and Moeschlin and Schnider, 1963). Moeschlin and Schnider 
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(1963) found that desferrioxamine is not absorbed if given enterally and 
recommended that it be given by intravenous drip or intramuscularly for 
systemic effects. Whitten e_t £l. (1965) worked with desferrioxamine in 
accidental cases of acute iron poisoning in children and experimentally 
produced cases in dogs. Although other workers have reported decreased 
enteral absorption of iron in the presence of desferrioxamine (Bannerman 
and Malpas, 1965), Whitten £t a^. (1965) found that it had no signif­
icant effect on iron absorption as did Brown et. (1967). 
Dogs poisoned with a dose equaling the of ferrous sulfate and 
treated one hour later with desferrioxamine orally and by intravenous 
drip showed only a 33% recovery (Whitten £t al. 1965). They also 
reported that the rapid administration of either desferrioxamine or 
ferrioxamine causes a fall in the mean arterial pressure. This fall in 
pressure is associated with an increase in the plasma histamine content, 
a tachycardia, and a tachypnea. 
Figure 2. Photograph showing conditions under which pigs were farrowed 
and housed during first seven weeks of the study. 
Figure 3. Photograph showing variation in size and condition of pigs 
at nine weeks of age, also conditions under which they were 
housed. 
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III, MATERIALS AND METHODS 
A. Experimental Design and Methods 
1. Animals 
A total of 50 pigs representing seven litters were used to obtain 
the data reported in this study. Pregnant crossbred sows were obtained 
from farm herds in the Ames area and allowed to farrow in farrowing 
stalls with concrete floors. The sows were released into exercise pens 
three times daily. Other than this the sows and pigs were housed in 
these stalls for the duration of the experiment (Figures 2 and 3). 
Table 1. Ration fed to dams before farrowing and during lactation 
Ingredient Percent of ration 
Corn, dent, grade No. 2 (yellow) 46.0 
Oats 20.0 
Wheat bran 5.0 
Soybean meal, solvent, 44% protein 16.4 
Dried whey 10.0 
Dicalcium phosphate 1.0 
Ground limestone 0.6 
Iodized salt 0.5 
Vitamin pre-mix* 0.5 
^Vita-plex, Vet-A-Mix, Shenandoah, Iowa. 
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2. Rations fed 
A 16.7% protein ration (Table 1) meeting the National Research 
Council requirements (1964) was fed to the dams prior to farrowing and 
during lactation. This ration, which contained no added iron, and the 
dam's milk were the only foods available to the pigs during the first 
seven weeks of the study. After this the soybean oil meal was in­
creased from 16.4 to 33% of the ration, and the pigs were weaned. The 
ration fed after weaning contained 22.2% protein. This was adequate in 
protein content but slightly low in total digestible nutrients according 
to the 1964 N. R. C. requirements. 
Table 2. Ration fed to pigs after weaning 
Ingredient Percent of ration 
Corn, dent, grade No. 2 (yellow) 36.9 
Oats 16.0 
Wheat bran 4.0 
Soybean meal, solvent, 44% protein 33.0 
Dried whey 8.0 
Dicalcium phosphate 0.8 
Gr ound 1ime s tone 0.5 
Iodized salt 0.4 
Vitamin pre-mix® 0.4 
^Vita-plex, Vet-A-Mix, Shenandoah, Iowa. 
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3. Iron chelation 
Two litters of pigs were used to study the efficacy of desferriox-
amine in chelating iron from pigs. Each pig received iron dextran^ 
injections, two ml. which supplied 150 mg. of elemental iron, between 
48 and 72 hours of age and again at 12 days of age. 
To allow for the collection of urine, which is necessary to determine 
the amount of iron lost, implants were placed in the urinary bladder on 
the 12th day of age, and the urethra was ligated so that all urine formed 
had to leave the bladder via the cannula. In nine pigs the exteriorized 
2 
cannula was connected to a 300 ml. serum transfer bag to allow for 
total collection of urine. These bags were emptied every eight hours. 
In addition to the collection of urine for the determination of iron 
excretion, the following measurements were made twice weekly: erythro­
cyte number, leukocyte number, packed cell volume, hemoglobin, differ­
ential leukocyte count, erythrocyte sedimentation rate, serum iron, and 
serum iron binding capacity. 
4. Immunization 
Between 12 and 24 hours of age the pigs in each litter were ear­
marked, weighed, and sexed. Between 48 and 72 hours of age the litter 
was divided at random into four groups two of which were treated with 
iron dextran. Pigs in the two control groups were given no supplemental 
Iperrextran, Fort Dodge Laboratories, Fort Dodge, Iowa. 
^Transpak, Abbott Laboratories, North Chicago, Illinois. 
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iron while treated groups were given two ml. of iron dextran which sup­
plied 150 mg. of elemental iron. All iron injections were given intra­
muscularly into the left rear leg. 
On the seventh day of age and every seven days thereafter for the 
duration of the study, the following determinations were made: body 
weight, erythrocyte count, total leukocyte count, packed cell volume, 
hemoglobin, differential leukocyte count, serum iron, and serum iron 
binding capacity. 
Of the two groups serving as controls, one served as an untreated 
control, while the other group was given daily injections of desferriox-
amine^ from the 18th day of life until the 36th day. Pigs treated in 
this manner were given two ml. of desferrloxamine in deionized water 
which supplied 200 mg. desferrioxamine. 
Of the two groups receiving iron, one group served to show the 
effects of adequate iron. These pigs were injected with two ml. of 
iron dextran on the 12th, 21st, and 30th day of life while the other 
group of pigs served as the iron-treated, desferrioxamine group. These 
pigs received a second injection of two ml. of iron dextran on the 12th 
day followed by daily injections of 200 mg. of desferrioxamine from the 
18th to the 36th day of life. 
On the 37th day and daily for the following three days pigs in all 
groups were injected intravenously with 12.5 mg. of cadmium-free equine 
ferritin^. Just prior to injection of equine ferritin and every third 
^Desferal, CIBA Pharmaceutical Company, Summit, New Jersey. 
^Pentex Incorporated, Kankakee, Illinois. 
day thereafter for 30 days, five ml. blood samples were collected for 
the determination of antibody titer to equine ferritin. The serum was 
removed by centrifugation and stored at -20° C until tested. 
5. Sheep erythrocytes 
Sheep blood was collected aseptically in an equal volume of sterile 
modified Alsever's solution and stored at four degrees centigrade until 
used for hemagglutination tests. Sheep erythrocytes were never used 
until they had been stored at least four days and can be used until they 
have been stored as long as two months or until evidence of hemolysis 
occurs. 
The modified Alsever's solution was prepared as follows: 24.6 grams 
of glucose, 9.6 grams of sodium citrate (dihydrate), and 5.04 grams of 
sodium chloride were dissolved in 1200 ml. of distilled water. The pH 
was then adjusted to 6.1 with citric acid, and the solution was ster­
ilized by passage through a filter (Seitz). 
6. Urine collection 
Due to the size of the urinary tract of the pigs used in this 
study and the necessity of obtaining urine which was not contaminated 
with iron from an external source, it was necessary to devise a cannula 
for permanent implantation. A photograph of the cannula is shown in 
Figure 4. This is a modification of the Zeman cannula (1966). 
To implant this cannula into the bladder, an incision 1 1/2 inches 
long was made from the pubis anteriorly. This exposed the bladder as 
well as the neck of the bladder and the urethra. The urethra was 
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double ligated with 0.40 nan. Vetafil^ suture material. Following this 
a purse string suture was placed in the wall of the urinary bladder, and 
a slit just long enough to accommodate the cannula was made through the 
bladder wall inside of the purse string suture. After placing the 
cannula in the bladder, the purse string suture was drawn up snugly 
and tied. Following this the stay apparatus and burr were fixed in 
place to permanently implant the cannula in the bladder. A length of 
polyethylene tubing was then attached to the cannula, and an incision was 
made through the abdominal wall but not through the skin. This opening 
was necessary to allow passage of the tubing from the abdominal cavity 
to the subcutaneous area. The tubing was then passed subcutaneously 
through a large bore needle anteriorly over the back and around the 
shoulder area and finally exteriorized on the floor of the chest. This 
area was chosen because it is a well protected area and, thus, protected 
the collecting apparatus (see schematic ^taping Figure 5). The tubing 
which was exteriorized was then connected to a 300 ml. serum transfer 
bag for continuous urine collection. Two coils were made in the tubing 
and placed subcutaneously to prevent disruption of the cannula and to 
allow for growth during the course of the experiment. 
An attempt was made to collect urine by placing the cannula direct­
ly from the bladder to the exterior as suggested by Zeman (1966). This 
was unsuccessful because of the age of the pig used in this study. The 
pig grows very rapidly during the first few weeks of life, and a cannula 
^Bengen and Company, Hannover, Western Germany. 
2 Transpak, Abbott Laboratories, North Chicago, Illinois. 
Figure 4. Photograph showing disassembled and assembled cannula 
which was used to collect urine from pigs. 
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Figure 5. Schematic drawing showing the positioning of the urine 
collecting apparatus in the young pig. 
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which is implanted solidly does not allow for growth. As a result of 
this, the cannula becomes nonfunctional in about ten days to two weeks. 
B. Experimental Techniques 
1. Urinary iron, serum iron, and iron binding capacity 
An automated procedure was developed and used for the deter­
mination of iron content of the urine, serum, and for the determination 
of serum iron binding capacity. The procedure developed was actually 
a modification of the Zak and Epstein (1965) procedure for automated 
determination of serum iron. It was found that to determine urinary 
iron by this method, best results were obtained if more time was 
allowed in the delay coils of the AutoAnalyzer^ and the range expander 
set at 4x. The delay was accomplished by inserting two delay coils 
instead of one and by running the samples at 60 per hour Instead of 40 
as Zak and Epstein did. The detailed procedure follows. 
With this procedure, iron released from serum transferrin, or 
ferrioxamine in the case of urine samples, by acid treatment in the 
presence of ascorbic acid causes reduction of the released iron to the 
ferrous state. This was then dialyzed into an acetate buffer capable 
of maintaining the iron in a diffusible state at a pH suitable for 
instantaneous and complete color formation with 4,7-diphenyl-l,10-
phenanthroline sulfonate. 
The reagents were prepared in the following manner: The ascorbic 
acid, hydrochloric acid solution was prepared by making a 1% weight to 
^AutoAnalyzer, Technicon Incorporated, New York, New York. 
38 
volume solution o£ ascorbic acid in 1.0 N HCl. This solution was 
prepared and used within three days. Any remaining solution was dis­
carded at the end of this time to guard against deterioration. 
The acetate buffer was prepared by dissolving 82.1 grams of sodium 
acetate in one liter of water while 57 milliliters of concentrated 
glacial acetic acid were mixed in another liter of water. These two 
solutions were then mixed to form the acetate buffer which had a pH of 
4.65. This solution also was never used for more than three days after 
it was prepared. 
The 4,7-diphenyl-l,10-phenanthroline sulfonate solution was pre­
pared by dissolvtHgr20 mg. of 4,7-diphenyl-l,10-phenanthroline sulfonate 
in 100 ml. of distilled deionized water. This solution has been found 
to be stable for more than a month but was never used in this study if 
it was over three weeks old. 
Stock standards were prepared by dissolving 0.1 of a gram of iron 
wire in five ml. of concentrated hydrochloric acid and then diluting this 
to one liter with deionized water. The working standards were then made 
from this stock standard by making dilutions as shown in Table 3. 
Samples were run at a rate of 60 per hour using a deionized water 
wash cup between standard or sample. 
All iron determinations were made using this automated procedure 
with the range expander set at 2x for serum iron and iron binding capac­
ity and at 4x for urine iron. Also, for the determination of urine iron 
it was necessary to run the urine sample as a blank to adjust for inter­
ference due to the color of the urine. To make this correction, it was 
necessary to subtract the found with the urine blank from the )\g.Z 
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Table 3. Dilutions used to prepare working standards for iron deter-
Milliliters 
of 
stock 
Milliliters 
of 
deionized H2O 
Concentration 
in 
0.2 99.8 20 
0.5 99.5 50 
0.75 99.25 75 
1.0 99 100 
2.0 98 200 
3.0 97 300 
4.0 96 400 
5.0 95 500 
found when reagents were added. This technique, subtraction of inter­
ference, has been used with many other chemical determinations and is 
valid. Complications in the determination of urinary iron content were 
encountered because of a change from acid to alkaline urine which occurs 
as the pigs begin to consume feeds other than milk. To avoid this 
difficulty, the urine samples were treated by dilution with 1.0 N HCl. 
This had the effect of driving off the CO2 before the sample was 
presented to the AutoAnalyzer, and consistent results could then be 
obtained. The dilution used was one part of urine to one part of 1.0 
N HCl. To correct for this dilution factor, all results on samples 
treated in this manner were multiplied by two. 
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To determine serum iron and iron binding capacity, the following 
procedure was used: 
One milliliter of a clear nonhemolyzed serum sample was transferred 
directly into an AutoAnalyzer cup for serum iron determination while 
another milliliter of the same sample was transferred to a centrifuge 
tube containing two ml. of iron stock solution containing 500 wg.%. This 
was mixed and allowed to stand for five minutes at which time 0.2 grams 
of light magnesium carbonate were added. The solution was then mixed 
periodically during the next 30 minutes after which the sample was 
centrifuged at 1500 r.p.m. for five minutes. One ml. of the clear 
supernatant was then transferred to an AutoAnalyzer cup and analyzed for 
iron binding capacity using exactly the same technique as used for serum 
iron. However, the results obtained must be multiplied by three to 
correct for the dilution encountered while saturating the serum with 
iron. 
A schematic of the apparatus used in the automated dialysis proce­
dure is presented in Figure 6. The tubing and cuvette portions of the 
manifold, but not the dialysis membranes, were siliconed with a water 
soluble silicone^. The sample after being automatically diluted with 
HCl, ascorbic acid solution, partitioned with air was delayed for 
approximately ten minutes by passing it through two sets of delay coils. 
It then entered one side of the dialyzer and diffused into a pickup 
stream of air-segmented acetate buffer. This solution was then auto­
matically mixed with a predetermined quantity of bathophenanthroline 
^Siliclad, Clay-Adams, Incorporated, New York, New York. 
Figure 6. 
• I 
Schematic drawing of the AutoAnalyzer setup used to 
determine serum iron, iron binding capacity, and urinary 
iron. 
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sulfonate solution and read at 534 nua. in a 15 mm. flow cuvette. 
2. Antibody titers 
The indirect hemagglutination test as described by Stavitsky and 
Arquilla (1955) was used to detect the ferritin antibody. Bis--
diazotized benzidine was prepared as described by Kabot and Mayer 
(1961). This was made by dissolving 0.46 gm. of benzidine in 95.0 ml. 
of water containing 3.0 ml. of 6N HCl and tetrazotized at four degrees 
centigrade with a solution of 0.35 gm. NaN02 in 5.0 ml. of water. The 
mixture was stirred at four degrees centigrade until no free nitrite 
could be detected with potassium iodide and starch paper strips. The 
solution was stored at -20° C in 1.0 ml. aliquots. Occasionally, a 
positive test for nitrite may persist for a period in excess of one 
hour. If this occurs, it indicates a slight error in weighing of the 
sodium nitrite and can be corrected by adding a minute amount of benzi­
dine which will immediately cause a negative reaction for free nitrite. 
Bis-diazotized benzidine prepared in this way was always checked for 
potency and was found to give the best results when used at a concen­
tration of 0.5 ml, added to 7.0 ml. of cold phosphate buffered saline at 
pH 7.3. Other laboratories report that the potency may vary so that 
quantities ranging from 0.4 to 0.7 ml. may be necessary to give good 
results. The color of properly prepared bis-diazotized benzidine should 
be a very light yellow. Any brownish discoloration indicates decom­
position. 
Two mg. of ferritin in 4.0 ml. of 0.85 percent NaCl were added to 
1.0 ml. of phosphate buffered saline at a pH of 7.3. One ml. of five 
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povront washed sheep erythrocytes suspended in 0.85 percent NaCl was 
then added to the ferritin solution. The bis-diazotized benzidine was 
thawed and 0.5 ml. added to 7.0 ml. of cold phosphate buffered saline. 
One-fourth ml. of this solution was then added to the ferritin-sheep 
erythrocyte suspension and incubated 10 minutes at room temperature with 
periodic gentle shaking. The sensitized cells were then sedimented by 
centrifuging for five minutes at 750 r.p.m. in a Sorvall model GLC-1 
centrifuge^. The sensitized cells were washed in 3.5 ml. of one percent 
normal rabbit serum, in 0,85 percent NaCl, and resuspended in 2.5 ml. of 
one percent normal rabbit serum in 0.85 percent NaCl. 
Phosphate buffered saline at pH 7.3 was prepared using Na2HP0^ and 
KH2PO4 in the following manner; a 0.5 molar solution of each of the 
salts in deionized water was prepared, and a stock solution of buffer was 
then made by mixing 85 ml. of 0.5 molar Na2HP04 with 15 ml. of 0.5 molar 
KH2PO4. To prepare the buffered saline solution, 20 ml. of the stock 
buffer solution and 8.183 grams of NaCl were mixed in deionized water 
quantity sufficient to make one liter-
Serum samples were thawed in a 37° C water bath and inactivated in 
a 56° C bath for 30 minutes. The serum was adsorbed with an equal volume 
of washed, packed sheep erythrocytes for 30 minutes at room temperature 
and serial two fold dilutions in one percent rabbit serum diluent 
starting with a 1:10 dilution. One drop from a 1.0 ml. pipette of the 
sensitized cell suspension was added to each serum dilution. After 
mixing by gentle shaking, the sensitized cells were allowed to settle. 
^Ivan Sorvall Incorporated, Norwalk, Connecticut. 
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and the test was read in four co six hours. A positive test is indi­
cated by a matt of cells covering the bottom of the tube and a negative 
test by the collection of the cells in a "button" at the bottom of the 
tube. The titer was expressed as the reciprocal of the highest dilution 
giving a positive reaction. 
3. Other hematologic determinations 
Hemoglobin concentrations were determined by the cyanmethemoglobin 
technique^. A Coleman junior model 6D spectrophotometer with a matched 
set of cuvettes was used to make all spectrophotometric determinations. 
The readings obtained were compared to a chart to convert them to 
hemoglobin concentration in grams percent. All samples were run in 
duplicate. 
Erythrocyte and leukocyte values were determined in duplicate using 
National Bureau of Standards certified pipettes, counting chambers, and 
cover glasses. The diluting fluids used were Gower's solution for red 
blood cell determinations and O.lN HCl for leukocyte determinations. 
Erythrocyte sedimentation rates were determined with Wintrobe 
hematocrit tubes. Readings were made one hour after the tubes were set 
up. 
Packed cell volumes were determined in duplicate by the micro-
hematocrit method. 
Method described in pamphlet (revised, 1962) from Hycell, 
Incorporated, Houston, Texas. 
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IV. RESULTS AND DISCUSSION 
A. Circulating Antibody Titer 
The large variances in the ability of the pigs used in this study 
to produce antibodies against equine ferritin make it difficult to do 
any meaningful statistical analyses of these data. Therefore, the data 
as collected are given in Tables 4, 5, 6, and 7. Examination of these 
tables shows that it is difficult to draw any definite conclusions as to 
differences among the four groups studied. It can very readily be seen 
that no pig produced detectable antibodies by three days post-injection, 
but most pigs produced low but detectable levels by six days post--
injection, and peak antibody levels were reached by 12 to 15 days post— 
injection in all groups. There was at least one pig in each group that 
produced little or no antibodies. 
It is of interest that the pig which gave the highest antibody 
response in the anemic desferrioxamine treated group died, as did the 
pig giving the highest antibody response in the anemic control group. It 
is possible that this is not, in fact, a higher antibody level but is 
instead a reflection of a degree of dehydration which is seen in these 
very anemic pigs. 
The only conclusion which can be drawn from these data is that the 
amount of iron which is available to the pig has very little effect, if 
any, on the pig's ability to produce antibodies. Also, one can conclude 
that the administration of desferrioxamine does not inhibit antibody 
production. 
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Further examination of these tables shows that pigs 102, 103, and 
104 gave high antibody titers six days after injection. These three 
pigs are all from the same litter, but no explanation can be given for 
this high titer at this time. It does not appear to be an interfering 
antibody since none was detected prior to administration of equine 
ferritin nor at three days after administration. 
Another trend which can be noted from these data is that the anemic 
control and the anemic desferrioxamine treated pigs tend to hold a 
higher level of antibody for a longer period of time. Generally, the 
iron-treated and iron-dextran, desferrioxamine treated pigs tend to show 
a rather rapid decline in antibody titer from the 15th day on while the 
titer of anemic pigs also declined but more slowly. This might be 
explained by a slower turn over of body proteins in anemic pigs. 
B. Urine Production 
A review of the literature provided no information on the amount 
of urine produced by a baby pig in a 24-hour period or, for that matter, 
in any given period of time. However, the Agricultural Research Council 
of England (1967) states that although the amount of milk produced by a 
lactating sow varies considerably, an average figure of approximately 
6.5 kg. of milk is produced by the lactating sow per day, and an aver­
age piglet consumes about 800 ml. of milk per day. As Table 15 shows, a 
baby pig between two and five weeks will gain approximately 3.3 kg. or 
about 157 grams per day. In other words approximately 20% of the milk 
consumed appears as an increase in body weight. Table 8 shows that 
approximately 560 ml. of urine are excreted per 24-hour period from the 
Table 4. Circulating antibody titers of anemic-desferrioxamine treated pigs 
Days post immunization 
Pig no. 0* 3 6 9 12 15 18 21 24 27 30 
104 a 2560 80 1280 350 - - 10 - -
203 - - 20 640 1280 1280 5120 2560 2560 320 
205 - - 20 320 320 40 - - - -
301 - 20 20 160 640 1280 5120 1280 640 640 
302 - 20 10 160 160 80 - - - -
303 - 40 40 320 2560 320 320 320 320 320 
406 - 320 160 5120 10240 2560 2560 1280 Died Died 
410 - 80 160 160 2560 1280 648 320 320 160 
Means - 380.0 63.8 1020.0 2260.0 855.5 1720.0 721.3 548.6 205.7 
Average of the means 863.9 
^No detectable antibody 
"k Sample collected just prior to immunization 
Table 5. Circulating antibody titers response of anemic pigs 
Days post immunization 
Pig no. 0* 3 6 9 12 15 18 21 24 27 30 
105 _a - - 80 20 - - - - -
204 - 20 20 320 640 640 1280 640 1280 320 
207 - 20 20 1280 2560 640 5120 2560 1280 Died 
306 - - 20 320 320 20 - - - Died 
307 - 20 80 640 640 40 80 40 - Died 
401 - 20 80 1280 1280 640 640 640 640 320 
405 - 80 40 640 1280 640 1280 640 640 160 
Means - 22.9 37.1 651.4 962.9 374.3 1200.0 645.7 548.8 200.0 
Average of the means 515.9 
^o detectable antibody 
*Sample collected just prior to immunization 
Table 6. Circulating antibody titers of iron-dextran treated pigs 
Days post immunization 
Pig no. 0* 3 6 9 12 15 18 21 24 27 30 
102 _ a 1280 80 160 160 - - - - -
103 - 1280 160 640 640 320 20 - - -
206 - - - - - 40 - - - -
308 - - 10 160 320 160 80 - - 80 
309 - 40 20 2560 640 160 40 - - -
310 j - - 10 320 640 640 320 640 2560 320 
402 40 20 320 80 160 320 - - -
404 - 20 20 2560 2560 1280 640 320 320 -
Means - 332.5 40.0 840.0 630.0 345.0 171.3 120.0 360.0 50.0 
Average of the mean 321.0 
^0 detectable antibody 
*Sample collected just prior to immunization 
Table 7. Circulating antibody titers of iron-dextran desferrtoxamine treated pigs 
Days post immunization 
Pig no. 0* 3 6 9 12 15 18 21 24 27 30 
101 a 160 640 1280 640 - - - - -
201 - - - - - 40 - - - -
202 - 20 40 320 20 - - - - -
304 - 20 20 40 80 40 1280 5120 1280 320 
305 - - - 320 320 10 - - - -
407 - 320 640 5120 10240 2560 1280 1280 640 160 
408 - 40 40 1280 1280 640 320 160 40 40 
409 - 40 20 640 2560 320 80 40 640 32 
Means - 75.0 175.0 1125.0 1692.5 451.3 370.0 825.0 325.0 105.0 
Average of the mean 571.5 
detectable antibody 
*Sample collected just prior to immunization 
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i2th to the 3ôth day of age. This accounts for about 70% of the total 
milk intake. This leaves only 10%^of the total intake to be lost in 
the form of feces and insensible loss, but the consumption of feed and 
water has not been taken into account. 
It is known that little pigs will consume from two to three lbs. of 
creep feed from birth to five weeks of age if it is available, and they 
will consume approximately 60.5 ml, of water per day in addition to that 
provided by the milk between the ages of one and three weeks. 
In addition to water from these sources, the pig also gets water 
which is formed in the process of metabolism. This source of water is 
very important, and, if these figures are correct, one would expect the 
baby pig to lose approximately 440 ml. of water per day in the form of 
insensible loss. Data presented here indicates that of this 440 ml., 
60.5 ml. are from water intake, approximately 80 ml. are from milk 
intake, leaving approximately 300 ml. unexplained which must come from 
metabolic sources. This appears to be more water than one would expect 
from metabolism, indicating that baby pigs used in this study either 
drank more water or milk than the average figures given in the liter­
ature indicate. 
C. Iron Excretion 
Iron excretion was followed for 25 days starting on the 12th day 
and continuing until the 36th day to obtain data on normal iron excre­
tion by the young pigs as well as to determine the efficacy of desferriox-
amine as iron chelating agent in the pig- Table 9 gives the results of 
this study. Urine was collected every eight hours, and its volume and 
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T —b 1 w 8 - ci-r oo r^ p{|v tiring* 1os<? in DIPS 
Average urine loss during day Total loss per day 
Age ml. ml. 
in days 0-8 hr. 8-16 hr. 16-24 hr. 
12 196.9 196.9 240 8 633.8 
13 211.7 214.4 191.4 8 617.5 
14 215.0 172.9 158.6 7 546.5 
15 240.0 215,7 248.8 7 704.5 
16 302.5 170.0 179.4 7 651.9 
17 241.0 186.7 156.7 7 584.4 
18* 213.6 220.0 245.0 7 678.6 
19* 211.7 203.3 199.3 7 614.3 
20* 314.2 225.7 211.4 7 751.3 
21* 225.0 228.0 195.0 7 648.0 
22* 234.2 196.2 114.0 7 544.4 
23* 217.9 190.0 194.2 7 602.1 
24* 215.0 143.0 155.0 7 513.0 
25* 161.0 218.3 163.3 6 542.6 
26* 215.0 163.0 167.0 6 545.0 
27* 182.0 218.0 191.0 6 591.0 
28* 257.0 227.5 203.0 6 687.5 
29* 243.0 177.0 171.0 6 591.0 
30* 193.0 146.0 140.0 6 479.3 
31* 197.0 132.0 131.7 6 460.7 
32* 194.0 107.5 113.3 6 414.8 
33* 142.1 121.7 166.7 6 430.5 
34* 124.2 91.7 138.0 6 353.9 
35* 212.5 117.5 97.5 4 427.5 
36* 145.0 107.5 103.2 4 355.7 
*Days on which desferrioxamine was injected 
^Number of pigs per time period 
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Urinary iron loss during day Total loss per day 
Age Ag. y Hg. 
in days 0-8 hr. 8-16 hr. 16-24 hr. N 
12 7.3 7.0 7.3 8 21.6 
13 7.5 7.4 6.1 8 21.0 
14 4.8 1.9 6.3 7 13.0 
15 4.4 1.2 3.9 7 9.5 
16 3.4 6.1 4.0 7 13.5 
17 3.4 2.4 5.2 7 11.0 
18* 119.7 35.1 3.8 7 158.6 
19* 122.1 37.3 9.9 7 169.3 
20* 149.9 26.5 10.4 7 186.8 
21* 116.1 36.4 17.1 7 169.6 
22* 132.3 32.2 6.3 7 170.8 
23* 89.7 21.2 12.1 7 123.0 
24* 62,5 17.0 6.3 7 85.8 
25* 77.2 6.8 4.3 6 88.3 
26* 80.9 9.8 3.4 6 94.1 
27* 58.3 29.5 0.9 6 88.7 
28* 61.7 18.9 5.9 6 86.5 
29* 43.3 19.6 23.4 6 86.3 
30* 53.0 13.1 6.0 6 72.1 
31* 31.6 17.7 10.2 6 59.5 
32* 26.3 12.9 7.4 6 46.6 
33* 25.8 21.6 6.5 6 53.9 
34* 22.7 15.2 6.5 6 44.4 
35* 30.0 12.0 5.2 4 47.2 
36* 16.1 8.3 6.1 4 30.5 
*Days on which desferrioxamine was injected 
^Number of pigs per time period 
1 a 
da; 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
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efforrq of iron dextran on the urinary excretion of iron by 
pigs 
Control Iron dextran 
Mean Mean Mean 
/Ag.X fAg.Vo njè'7. 
Pig 14 Pig 12 Pig ^ 
6 30 24 
6 15 25 
8 :  . 1 6  19 
5 25 9 
7 15 16 
7 21 21 
8 14 8 
9 20 13 
2 30 20 
0 9 27 
6 22 11 
8 13 12 
9 7 21 
12 14 13 
6 22 14 
9 27 8 
8 36 7 
56 
iron content were determined, by multiplying these two values the amount 
of iron excreted during each eight-hour period could be determined. The 
addition of the three eight-hour periods in each day gave the daily iron 
excretion. 
Examination of Table 9 shows that from the 12th through the 17th 
day the average daily iron excretion was 14.93 On the 18th day and 
every day thereafter until the 36th day each pig was injected with 200 mg. 
of desferrioxamine I.M. It can be seen that this treatment dramatically 
increased iron excretion at the beginning of the treatment period. Daily 
iron excretion increased to 10.5 times control levels and then gradually 
sloped off until by the 18th day the excretion was approximately two 
times control levels. 
Further examination of this table shows that the greatest excretion 
of iron occurs during the eight-hour period following desferrioxamine 
injection. This confirms the work of Yunice et al. (1968) and Walsh 
et al. (1965) who worked with other species. Very little increased iron 
excretion is seen due to desferrioxamine during the eighth to 16th hour 
period after injection, and the iron excretion is essentially at normal 
levels from the 16th through the 24th hour after injection. 
Table 10 gives values for the amount of iron lost in the urine of 
two iron-treated pigs and for one iron-deficient pig. These values are 
given as in the urine. Although these pigs were permanently 
catheterized, total urine collections were not made, but the bladder was 
emptied five times daily, and midstream samples were collected and pooled 
for analysis. The data presented in this table indicate that the 
57 
HT-inary iron content of the anemic pig is lower than that of the iron-" 
treated pigs during the course of the 17-day period. 
Table 11 presents data collected on three iron-treated pigs which 
were treated with desferrioxamine from the 10th to the 17th day of the 
study. Samples were collected in the same way, but after desferrioxamine 
treatment was started, samples collected during each period were kept 
separate for analysis. Three levels of desferrioxamine treatment were 
used. One pig received 100 mg. of desferrioxamine daily, a second 
received 200 mg. per day, and a third received 300 mg. per day. Exam­
ination of the data reveals that the urine iron content is consistently 
lower at the 100 mg. treatment level than at the two higher levels 
although there is not much difference between the 200 and 300 mg. treat­
ment levels. The decision to use 200 mg. of desferrioxamine per day for 
the remainder of the study was based on these data. 
The data presented in the table also clearly indicate that the iron 
which is excreted because of desferrioxamine is excreted within the first 
15 hours after injection and by far the largest part is excreted by 10 
hours after injection. 
D. Desferrioxamine Toxicity 
During the course of the experiments, the pigs were closely ob­
served for clinical signs of desferrioxamine toxicity. At no time were 
any signs of toxicity observed. The pigs had very little if any tissue 
reaction at the site of injection because there were no visible signs of 
inflammation at any time during the course of the study nor were there 
any lesions observed when histological studies were made on tissues from 
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TaKla n. of desferrioxamine on the urinary excretion of iron 
by iron -treated pigs 
Age wg.%= Age Ag.% Wg'% 
in days Pig 16 Pig 18 Pig 19 in days , Pig 16 Pig 18 Pig 19 
18 13 15 17 31* 60 121 75 
19 23 28 23 60 76 57 
20 19 13 14 26 32 31 
21 6 21 23 13 18 13 
22 7 14 13 21 21 16 
23 6 15 21 32* 54 70 92 
24 8 16 13 51 46 23 
25 12 17 20 38 22 35 
26 18 13 14 16 18 22 
27 d 13 20 15 17 18 23 
28* 88 120 135 33* 58 90 104 
54 83 78 62 31 116 
20 97 92 43 37 84 
17 28 23 25 20 39 
12 14 14 9 14 30 
29* 92 106 109 34* 50 107 92 
66 96 92 43 83 57 
23 29 37 46 56 25 
19 32 24 7 32 29 
7 15 9 13 21 24 
30* 60 97 121 35* 46 32 25 
53 88 . 84 37e 30 32 
31 41 16 24 21 
9 16 9 - 43 13 
11 20 14 
*Days on which desferrioxamine was injected 
^Pig 16 received 100 mg. of desferrioxamine per day by I.M. injection 
^ig 18 received 200 mg. of desferrioxamine per day by I.M- injection 
'rig 19 received 300 mg. of desferrioxamine per day by I.M. injection 
"Values given for days 28-35 are urinary iron content of samples 
collected five times daily and analyzed separately 
^Indicates no sample collected 
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Che in iecc ion s i te .  
Two anemic-desferrioxamine-treated pigs were selected at random for 
postmortem examination after they had received daily desferrioxamine 
injections for 18 days. The postmortem examination revealed the 
following: 
The pigs were stunted, and pallor was noted in all tissues. These 
observations can be made on any pig which has a severe iron-deficiency 
anemia and are believed to be associated with the iron deficiency rather 
than having anything to do with the administration of desferrioxamine. 
There were no gross lesions observed. Histological examination of 
tissues saved from these pigs showed reticuloendothelial hyperplasia of 
the white and red pulp of the spleen and a moderate degree of extra--
medullary hematopoiesis. Other tissues which were examined micro­
scopically included the kidney, liver, lung, adrenal gland, pancreas, 
jejunum, and lymph nodes. None of these tissues showed any sign of 
toxicity due to the desferrioxamine. 
Two pigs which had received iron injections at two and 12 days of 
age, which was followed by desferrioxamine from the 18th to 36th day, 
were selected for postmortem examination. Gross examination revealed no 
lesions, but again the spleens showed marked reticuloendothelial hyper-
piasii" of the white pulp and marked extramedullary hematopoiesis. 
Histological examination of other tissues which were saved, again showed 
no lesions, indicating that desferrioxamine is relatively nontoxic in 
the iron-treated pig. These pigs were not stunted and showed no differ­
ence in growth rate from their litter mates which received iron but no 
desferrioxamine. 
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One pig which had received no iron but had received desferrioxamine 
from the 18th to the 36th day of life was selected for postmortem 
examination at 70 days of age. Gross examination revealed no lesions, 
but microscopic examination revealed reticuloendothelial hyperplasia of 
the red pulp and extramedullary hematopoiesis. In addition, the liver 
showed fatty change and had areas of active hematopoietic tissue. These 
apparently were associated with the anemia rather than with the 
desferrioxamine which had been administered. All other tissues examined 
were normal. 
One pig which received iron on the second and 12th day of life and 
then desferrioxamine from the 18th to the 36th day of life was necropsied 
at 70 days of age. This pig showed no gross or microscopic lesions of 
any kind which could be associated with desferrioxamine. 
E. Serum Iron, Iron Binding Capacity, and 
Residual Iron Binding Capacity 
Tables 12a, 13a, and 14a show the effects of iron dextran and 
desferrioxamine on serum iron content, residual iron binding capacity, and 
serum iron binding capacity, respectively. 
Significant differences in the serum iron content can be seen at 
five weeks of age in those pigs which served as controls. This shows that 
after desferrioxamine had been administered to the anemic control pigs 
for a period of 17 days, a significant decrease in serum iron content 
could be produced. However, since desferrioxamine injection was termi­
nated at this time, this difference was soon lost. This same difference 
is observed between iron-treated groups. Desferrioxamine again produced 
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a significant difference which was somewhat more persistent and co ild 
be observed at the fifth, sixth, and eighth weekly determinations. 
Significant differences between the anemic-control groups and the 
iron-treated groups could be seen throughout the course of the study as 
was expected. Cartwright and Wintrobe (1948) stated that iron-deficiency 
anemia resulted in a marked hypoferremia with an average serum iron 
content of 31 + 7.2 /tg.% while pigs having adequate iron had serum iron 
levels of 169 + 38.8 )(g.%. Dvorak (1965) reported average serum iron 
levels of 109 /tg.% for pigs averaging 46 days of age, but his pigs were 
somewhat anemic because the hemoglobin levels he reports were only 
7.5 gm.%. 
Working with pigs from one week to six weeks of age Shireman (1966) 
reported mean values ranging from 59.9 to 74.9 Hg.% for anemic-control 
pigs while the serum iron content of iron-injected pigs ranged from 
104.5 to 145.2 xg.% during this same period of time. 
The results reported herein agree quite closely with those of 
Cartwright and Wintrobe (1948) so far as serum iron content is concerned 
although the values found are slightly lower for iron-deficient pigs 
than those reported by these workers, and the levels for iron-treated 
pigs are slightly higher. 
While the work of neither Shireman (1966) nor Dvorak (1965) agrees 
with the work reported herein, they do agree with each other. This can 
be explained by the degree of anemia seen in the pigs with which they 
worked. Shireman's iron-deficient pigs had hemoglobin values approx­
imately equal to those of Dvorak's pigs, and the iron-treated pigs were 
slightly anemic. 
Table 12a. Effects of iron dextran and desferrioxatnine on the serum iron of pigs 
Controls* Iron dextran* Slfinificant differences^ 
Age Mean 
Mg.% 
Desferrioxagine 
Mean S 
>xg.% 
Mean 
/tg.% 
S* 
Desferrioxagine 
Mean S A/B A/C A/D B/C B/D C/D 
Ak Cb D*) 
1 wk. 21.7 4.7 17.9 3.4 165.1 49.1 150.0 46.6 * * * * 
2 wk. 21.6 3.8 18.0 4.4 244.8 78.1 266.7 60.52 * * * * 
3 wk. 21.6 5.7 15.8 7.0 205.1 64.2 178.6 53.6 * * * * 
4 wk. 21.6 6.2 16.5 6.4 190.5 56.3 150.3 25.3 * * * * 
5 wk. 25.4 8.3 15.6 4.72 171.6 41.4 115.5 28.9 * * * * * * 
6 wk. 26.1 6.5 19.6 6.8 178.6 56.4 114.5 31.0 * * * * * 
7 wk. 28.3 11.3 26.8 21.6 185.6 39.0 145.8 54.1 * * * * 
8 wk. 53.0 71.9 46.4 40.6 193.1 32.3 151.4 34.0 * * * * * 
9 wk. 49.14 51.7 83.4 68,3 181.3 20.2 181.0 49.7 * •k * * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 12b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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Table 12b. Degree of significant differences indicated in Table 12a. 
Eftects or iron aexcran ana ôesîeti ioAomiuc On Cl.a seruii 
iron of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. *** *** *** *** 
2 wk. *** * * * *** *** 
3 wk. **. *** *** *** 
4 wk. *** *** *** 'A"A"A 
5 wk. * 'AAA' A A A  *** *** ** 
6 wk. A A A  A A A  *** A A *  *  
7 wk. A A A  A " A " A  A A A  A A A  
8 wk. A A A  *** A A A  A " A -A ** 
9 wk. A A *  A A A  -A-A'A' ** 
*P < 0.05 
**P<[ 0.01 
0.005 
Table 13a. Effects of iron dextran and deaferrioxamine on the residual iron binding capacity 
of pigs 
Controls* Iron dextran* Significant differences^ 
De s ferr ioxamine De s ferr ioxamine 
Age Mean S® Mean S® Mean S® Mean S® A/B A/C A/D B/C B/D C/D 
Rg.% >\g.% ftg.% 
Ab Cb D*) 
1 wk. 486.4 129.2 395.3 116.6 146.5 72.7 226.6 178.4 * * * * 
2 wk. 755.9 173.8 648.0 98.8 146.5 77.7 146.9 149.3 * * * * 
3 wk. 826.6 154.2 785.4 116.5 230.4 95.8 303.5 93.4 * * * * 
4 wk. 803.9 70.2 809.4 59.2 171.4 87.7 245.5 90.7 * * * * 
5 wk. 796.4 110.5 527.4 56.9 195.4 33.7 327.8 108.7 * * * * * * 
6 wk. 747.1 70.4 787.0 35.7 228.0 77.8 399.6 103.3 •k * * * * 
7 wk. 674.6 68.9 704.5 71.13 303.3 62.0 405.4 95.6 * * * * * 
8 wk. 665.7 147.3 664.6 65.6 267.9 98.4 397.1 53.9 * * * * 
9 wk. 674.6 131.2 531.0 127.8 347.5 66.4 343.6 104.3 * * * * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
"'"Significant difference of the means as determined by the use of the least significant 
difference test (see Table 13b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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DcgTCC of dIfferenrmR indicated in Table 13a. 
Effects of Iron dextran and desferrioxamlne on the residual 
iron binding capacity of pigs 
Significant difference 
Age A/B A/C A/D B/C B/D C/D 
1 wk. *** ** *** * 
2 wk. * A* *** *** •*** 
3 wk. *** *** *** *** 
4 wk. *** *** A'** *** 
5 wk. *** *** *** A A A  A A A  * *  
6 wk. *** *** *** *** *** 
7 wk. A 'AA *** AA' A' *** * 
8 wk. *** *** AA-A AA* ** 
9 wk. *** *** *** ** 
*P<^ 0.05 
**P<^0.01 
***P <^0.005 
Table 14a. Effects of Iron dextran and desferrioxamlne on the serum Iron binding capacity 
of pigs 
XX 4' Controls Iron dextran Significant differences 
Desferrioxamlne Desferrioxamlne 
Age Mean Mean Mean S® Mean S® A/B A/C A/D B/C B/D C/D 
.b _b „b A B C D 
1 wk. 507.9 233.4 414.4 104.3 311.6 67.0 375.4 160.9 * 
2 wk. 748.9 345.3 666.0 166.8 390.6 91.0 412.9 120.5 * * * * 
3 wk. 848.1 361.8 781.1 112.8 435.5 83.6 481.9 761,. 6 * * 
4 wk. 825.4 323.7 826.5 57.2 364.5 70.9 396.6 78'. 5 * * * * 
5 wk. 821.9 332.8 843.0 55.0 366.0 54.9 443.3 98.4 * * * * 
6 wk. 780.4 308.2 806.6 37.4 407.6 43.8 514.1 94.1 * * * * 
7 wk. 702.9 276.5 731.3 75.0 434.9 166.2 551.5 97.5 * * * 
8 wk. 718.7 291.4 711.6 80.1 486.0 79.7 547.5 64.4 * * * 
9 wk. 722.6 292.4 614.3 103.5 528.8 58.4 525.5 119.8 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
"^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 14b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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xaoie 14b. Degtcc oI aignificar^t diffcrcr.ccc indicated ir. T?-ble 14* 
Effects of iron dextran and desferrioxamine on the serum 
iron binding capacity of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. * 
2 wk. *** * *** *** 
3 wk. *** *** 
4 wk. * * *** *** 
5 vk. * * *** *** 
6 wk. * *** *** * 
7 wk. * *** *** 
8 wk. * *** *** 
9 wk. 
*P<^ 0.05 
**P 0.01 
***P 0.005 
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Thf> effects of iron dexcran and desferrioxâmine on residual iron 
binding capacity are given in Table 13a. These results closely parallel 
those of serum iron (Table 12a) as would be expected because as a general 
rule as the serum iron decreases, the residual iron binding capacity 
increases. Because of this, significant differences are seen at the same 
periods of time when significant differences are seen in serum iron 
content. 
Table 14a gives the effects of iron dextran and desferrioxamine on 
total iron binding capacity of pigs. These data clearly show that the 
total iron binding capacity of pigs which are iron treated is much lower 
than the iron binding capacity of those which are anemic. These results 
are consistent with results which have been published by many workers in 
the human field (Laurell, 1952; Dvorak, 1965; and Cartwright et al. 
1949). These workers gave values approximately 315 pg.% for the normal 
adult human and values approximately 400 for iron-deficient anemic 
individuals. 
The results reported herein are in direct contradiction with those 
reported for swine by Shireman (1966) and Cartwright and Wintrobe (1948). 
These workers found the iron binding capacity to be reduced rather than 
increased in iron-deficient pigs. Cartwright and Wintrobe (1948) gave 
values of 845 y^.% for normal swine, 298 for protein-deficient 
swine, and 540 /^g.% for iron-deficient swine. 
Shireman (1966) found values much lower than those of Cartwright 
and Wintrobe. Values given for iron dextran treated pigs range from 
418 + 85.8J4g.% at one week of age to 454 + 39.4 y^'% at five weeks of 
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age while the iron-deficient pigs gave values of 383.9 +62.1 at one 
week of age to 359 + 70.4 at five weeks of age. Shireman suggested 
that the differences between the findings on swine might be due to age 
while the differences between swine and human values might be a species 
difference. 
The attempts to substantiate these findings failed; therefore, the 
results reported herein do not agree with these workers. The variance 
in results may be due to a difference in procedures used to determine 
these values although this seems unlikely. 
F. Body Weight 
The data on body weights are included in this thesis to show the 
effects of iron dextran on body weight under the conditions used in this 
study. Although iron-treated pigs which subsequently received desferrlox-
amine became slightly anemic, they showed no significant difference in 
body weight from those receiving iron (Figure 8). However, significant 
differences In body weight can be seen between iron-treated and non— 
iron-treated pigs after three weeks of age (Figures 9 and 10). This 
difference in weight is probably due to the experimental design rather 
than a true effect of iron. When anemic and non-anemic pigs are housed 
together, the non-anemic pigs tend to deprive the anemic pigs of adequate 
nourishment. 
Table 15a gives the mean body weight plus or minus one standard 
deviation as well as the significant differences between means at the 
95% confidence level as determined by the test for least significant 
Figure 7. General appearance of two anemic littermate pigs. Pig on 
the left received desferrioxamine while pig on the right 
served as untreated control. 
Figure 8. General appearance of two iron-treated littermate pigs. Pig 
on the left received iron dextran injections followed by 
desferrioxamine while the pig on the right served as an iron--
treated control. 
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Figure 9. General appearance of littermate anemic control pig (left) 
and iron-dextran created pig (right). 
Figure 10. General appearance of litLermate anemic desferrioxamine 
treated pig (left) and iron-dextran treated pig (right). 
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At the end of the ten-week study period the iron-treated pigs 
weighed approximately twice as much as the anemic pigs; whereas, at the 
beginning of the study the weights were about equal. This difference of 
body weights of pigs in experiments designed as this one has been found 
previously (Kunesh, 1966). It is of further interest that this differ­
ence in body weight and rate of gain had little or no effect on antibody 
production (Tables 4, 5, 6, and 7). 
It will be further noted that seven to eight weeks of age is appar­
ently a critical period of time in the life of the anemic pig. Under 
the circumstances of this experiment many of the anemic pigs lost weight 
during this period of time while the iron-treated pigs continued to gain 
weight. 
Treatment with desferrioxamine had no significant effect on body 
weight (Figures 7 and 8). The observation that anemic, desferrioxamine— 
treated pigs weighed slightly more than controls after the fifth week 
of the study is believed to be coincidence, and no importance is at­
tached to it. 
G. Other Hematologic Observations 
The hemoglobin values (Table 16a) in this study compared quite 
favorably with the values found by Coulter (1965) and to those found by 
Talbot and Swenson (1963) during the first three weeks of their study. 
Values found by Kunesh (1966) were slightly higher for anemic pigs and 
slightly lower for iron-treated pigs. This was probably due to a 
difference in housing conditions and access to the sow's feed. The 
Table 15a. Effects of iron dextran and desferrioxamine on body weights of pigs 
Controls* Iron dextran* Significant differences^ 
Desferrioxamine Desferrioxamine 
Age Mean S® Mean S® Mean S® Mean S® A/B A/C A/D B/C B/D C/D 
kg. kg. kg. kg. 
A»^ B^ c" Db 
Birth 1.4 0.3 1.6 0.2 1.5 0.1 1.6 1.0 
1 wk. 2.4 0.4 2.6 0.3 2.6 0.3 2.6 0.2 
2 wk. 3.7 0.7 3.8 0.6 3.9 0.8 4.1 0.4 
3 wk. 4.7 0.7 4.6 0.5 5.2 0.8 5.4 0.5 * * 
4 wk. 5.0 1.0 5.3 0.8 6.5 1.0 6.3 0.9 * * * * 
5 wk. 5.8 1.1 6.1 1.2 8.3 1.4 8.5 0.5 * * * * 
6 wk. 6.0 1.8 6.7 1.2 10.5 1.4 10.7 0.7 * * * * 
7 wk. 6.6 1.8 7.4 1.0 11.8 2.0 13.0 1.2 * * * * 
8 wk. 6.3 2.9 7.2 1.9 13.2 2.3 14.5 1.7 * * * * 
9 wk. 6.6 3.7 8.8 2.8 16.2 2.8 16.3 2.1 * * * * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n => 7 
"^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 15b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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Effects of iron dextran and desferrioxamine on body 
weights of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
Birth 
1 wk. 
2 wk. 
3 wk. * ** 
4 wk. * * * * 
5 wk. A A A  A A A  *** A A A  
6 wk. *** AAA A'A"A A "A A' 
7 WK. *** A A A  *** *** 
g wk. AAA AAA AAA *** 
9 wk. *** AAA AAA AAr* 
*P <^0.05 
**P<^0.01 
***p <^0.005 
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sec by Schalm (1965). The conditions under which pigs are raised play 
an important role in the degree of anemia which is attained. The pigs 
in this study had access to no exogenous source of iron other than 
that which was injected, a small amount of the sow's ration (Table 1) 
or weaning ration (Table 2), and that from the dam's milk. A similar 
experimental situation was present for the work done by Coulter (1965), 
Talbot (1963), and Kunesh (1966). This may explain the close correla­
tion of the values which were found. 
Pigs receiving no iron in this study showed a gradual decline in 
hemoglobin levels during the first five weeks of life and then showed a 
gradual increase during the last five weeks. This apparently was 
associated with an increased consumption of feed which contains more iron 
than the dam's milk. 
The pigs which were treated with iron showed a steady increase in 
hemoglobin levels for the first three weeks. Then the iron-dextran, 
desferrioxamine treated group showed a decline until at five weeks of 
age %Aen there was a significant difference between the Iron-dextran, 
desferrioxamine treated group and the iron-dextran treated pigs. After 
the fifth week the hemoglobin levels of both groups continued to fall, 
but significant differences between the two groups were lost. 
Statistical analysis shows that hemoglobin levels of anemic control 
pigs were significantly different from those of iron-treated pigs during 
the entire study. Significant differences between anemic groups could 
not be demonstrated; however, at five weeks of age the hemoglobin levels 
Table 16a. Effects of Iron dextran and desferrloxamlne on hemoglobin values of pigs 
Controls* Iron dextran* Significant differences^ 
Desferrioxamine Desferrioxamine 
Age Mean S® Mean S® Mean S® Mean S® A/B A/C A/D B/C B/D C/D 
gm.% gin.% gm.7, gm.% 
1 wk. 8.1 1.1 7.7 0.8 9.7 1.0 9.8 0.8 * * * * 
2 wk. 5.1 0.9 5.4 0.7 11.1 1.3 11.0 1.1 * * * * 
3 wk. 4.1 0.5 4.3 1.0 12.4 1.5 12.4 1.0 * * * * 
4 wk. 3.5 1.0 3.4 0.6 11.9 1.0 11.5 0.7 * * * * 
5 wk. 2.8 1.1 2.9 0.9 12.4 0,6 10.9 0.8 * * * * 
6 wk. 3.6 1.7 3.4 1.1 11.5 1.3 10.7 0.9 * * * * 
7 wk. 3.5 2.5 3.6 1.3 11.5 2.3 10.1 1.0 * * * * 
8 wk. 4.4 1.7 4.6 1.6 11.0 1.4 9.8 1.1 •k * * * 
9 wk. 4.9 0.9 5.0 1.9 10.1 0.8 9.7 1.0 * * * * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
"'"Significant difference of the means as determined by the use of the least significant 
difference test (see Table 16b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparison 
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Table 16b. Degree of signif icair.t differences indicated in Table 16a. 
Effects of iron dextran and desferrioxamine on hemoglobin 
values of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. * ** *"A"A *** 
2 wk. *** *** *** *** 
3 wk. *** *** *** *** 
4 wk. *** *** A A A  A A A  
5 wk. A"A' A' A A A *** A A* *** 
6 wk. A A A  *** A A A  A * A " 
7 wk. A'** AAA A A* A-A-A 
g wk. AAA AAA AAA *** 
9 wk. AAA AAA *** A'** 
*P 0.05 
**P 0.01 
***P 0.005 
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vcrc cigr.ific^ntly ir*. the trmn-Hoyrran. Hesferrioxamine treated 
pigs as compared with iron-dextran treated pigs. Unfortunately, 
desferrioxamine injections were stopped at five weeks of age, and, as 
a result, this difference was soon lost. 
The packed cell volumes (Table 17a) are very readily correlated 
with the hemoglobin values found in this study. It is of interest that 
although the hemoglobin values correlate quite closely to the values 
found by Coulter (1965) and Talbot (1963), the PCV values averaged 
approximately three to five percent less during the first three weeks, 
but they compared favorably with values found by Kunesh (1966). 
The PCV's seen in this study steadily declined in the anemic groups 
during the first five weeks of the study and then steadily increased 
during the last four weeks. This is believed to be associated with the 
feed consun^tion of the pig. At no time during the course of the study 
could significant differences be shown between the two groups of anemic 
pigs. The iron-treated pigs gave results which are quite different. 
Both groups increased steadily for the first three weeks of the study 
after which both groups steadily decline, but the iron-dextran, 
desferrioxamine treated pigs showed a much more rapid decline so that 
significant differences between these two groups were demonstrated from 
the fifth through the seventh week of the study. 
The packed cell volumes compared very well with those cited by Schalm 
(1965) for pigs of the same age which are non-anemic. It can be said 
that anemic pigs used in this study had lower hemoglobins, RBC, and PCV 
levels than those reported by other workers with the exception of those 
found by Kunesh (1966). 
Table 17a. Effects of iron dextran and desferrioxamine on packed cell volumes of pigs 
Controls* Iron dextran* Significant differences^ 
Desferrioxamine Desferrioxamine 
Age Mean S® Mean S® Mean S° Mean S® A/B A/C A/D B/C B/D C/D 
% % % % 
A" B^ ct D" 
1 wk. 27.1 4.6 25.6 2.0 31.8 3.9 32.8 1.5 * * * 
2 wk. 18.1 1.2 19.1 2.4 36.5 3.1 36.5 3.5 * * * * 
3 wk. 15.5 1.4 16.4 2.8 39.1 4.8 38.4 4.3 * * * * 
4 wk. 13.9 4.6 13.1 1.7 36.8 2,4 35.2 2.8 * * * * 
5 wk. 12.7 3.9 12.0 2.9 37.0 1.8 32.6 2.0 * * * * * 
6 wk. 14.1 5.6 14.7 3.6 35.5 3.1 32.1 2.4 * * * * * 
7 wk. 14.8 7.1 15.4 3.7 36.4 3.8 32.3 2.4 * * * •k * 
8 wk. 15.6 10.0 19.0 6.6 34.8 4.5 31.4 3.7 •k * * * 
9 wk. 17.3 9.2 20.1 6.8 32.8 4,1 32.5 4.1 * * * * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
^Significant difference of the means as determined by use of the least significant 
difference test (see Table 17b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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Table i/b. Degree ot wign i i i canc  d i t l e rencea  i nû i co tou  l u  ï ab l c  17a. 
Effects of iron dextran and desferrloxamine on packed cell 
volumes of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. ** *** *** 
2 wk. *** AAA *** A'A'A' 
3 wk. *** *** *** AAA 
4 wk. AAA AAA  AAA  **•* 
5 wk. *** AAA *** *** A'A'A' 
6 wk. *** AAA AA"A ' A A* * 
7 wk. *** *** *** *** * 
8 wk. *** *** *** *** 
9 wk. *** *** AAA *** 
*P <^0.05 
**p <^0.01 
***P <^0.005 
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Table iôa givcs the crythrccyte which were found in this 
study. The numbers found for iron-treated pigs compare favorably with 
other reports in the literature (Talbot, 1963; Coulter, 1965). However, 
those values found with anemic pigs are generally lower than those found 
by other workers. The findings agree quite closely with those found by 
Kunesh (1966). Again, the degree of anemia produced is dependent on the 
housing conditions, and no particular significance can be placed on these 
findings other than to use them as an index to determine the degree of 
anemia of the experimental animals used. 
The effects of iron dextran and desferrioxamine on the sedimenta­
tion of erythrocytes are given in Table 19a. Examination of this table 
reveals that there were no significant differences in sedimentation rate 
between anemic pigs and anemic-desferrioxamine treated pigs at any time 
during the course of the study. However, there was a significant 
difference between the anemic groups and the iron-dextran treated group 
throughout the entire study period. This same observation was made by 
Shireman (1966), but to date no good explanation for this phenomenon has 
been found. 
Significant differences were also observed between anemic pigs and 
the iron-dextran, desferrioxamine treated pigs during the first five 
weeks of the study. This is because desferrioxamine was 
not administered during the first 18 days of the study, and, after 
administration was started, it took several days to deplete the body's 
iron stores. It was further observed that at five weeks of age, which 
was the age when maximum iron depletion was accomplished, the sedimenta­
tion rate of the iron-dextran treated and the iron-dextran, desferriox-
Table 18a. Effects of iron dextran and desferrioxamlne on the number of erythrocytes per 
cubic millimeter of blood of pigs 
Controls* Iron dextran Significant differences 
g Desferrioxamlne Desferrioxamlge 
Age Mean S Mean S Mean S Mean S A/B A/C A/D B/C B/D C/D 
(xl06) (xlO*) (xlO®) (xlO*) 
A»> B^ C»' 
1 wk. 5.3 0.8 5.0 0.8 5.7 0.7 5.5 0.8 
2 wk. 4.5 0.7 4.9 1.0 6.4 0.7 6.7 0.7 * * * * 
3 wk. 4.1 0.5 4.1 0.5 6.2 1.0 6.3 0.7 * * * * 
4 wk. 4.0 1.2 3.9 0.7 6.5 0.9 6.1 0.5 * * * * 
5 wk. 4.0 1.1 3.7 0.8 7.0 0.8 5.7 0.6 * * * * * 
6 wk. 4.4 1.5 4.5 1.2 6.5 0.6 6.2 0.6 * * * * 
7 wk. 4.3 1.6 4.5 1.3 6.9 1.0 6.2 1.0 * * * * 
8 wk. 5.2 1.5 5.6 2.0 6.8 1.8 6.4 1.1 
9 wk. 5.7 1.6 6.1 2.0 6.5 1.0 6.5 1.6 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 18b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
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T?ble 18b of significant differences indicated in Table 18a. 
Effects of iron dextran and desferrioxamine on the number 
of erythrocytes per cubic millimeter of blood of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. 
2 wk. *** *** 
*** 
*** 
3 wk. *** *** *** *** 
4 wk. *** *** *** *** 
5 wk. *** *** *** *** 
6 wk. *** * *** *** 
7 wk. * * *** * 
8 wk. 
9 wk. 
*P <^0.05 
**p <[[o.oi 
***P <^0.005 
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amine treated pigs was significantly different. Unfortunately, at this 
point the desferrioxamine injection was stopped, and this significance 
was soon lost. Part of the reason that this significance is lost is due 
to the high standard deviation of the iron-dextran, desferrioxamine 
treated pigs. 
The leukocyte count (Table 20a) shows that the control pigs tend 
to have lower levels of circulating white blood cells than iron treated 
pigs. During the entire course of the study, there was a trend toward 
increasing numbers of leukocytes in all groups. However, it should be 
noted that the leukocyte nunter in the iron treated pigs increased much 
more rapidly. 
Examination of analysis for least significant differences of the 
means shows that the leukocyte numbers of anemic pigs are significantly 
lower than those of iron-treated pigs from the second week through the 
eighth week of the experiment. It is believed that the increasing 
leukocyte numbers are characteristic of pigs raised under conditions 
similar to those used in thlp study. 
The leukocyte numbers found in this study are higher than those 
found by Coulter (1965) or Kunesh (1966). They are also higher than those 
found by Seamer (1956) who reports that a slight leukopenia should accom­
pany iron deficiency. They are also slightly higher than those reported 
by Ullrey et al. (1959) who reports no significant difference between 
iron-injected and control pigs up to five weeks of age. 
The values reported for this study were corrected for nucleated red 
cells as were those reported by Coulter (1965) and Kunesh (1966). Coulter 
Table 19a. Effects of iron dextran and desferrloxamlne on the sedimentation rate of 
erythrocytes of pigs 
XX + 
Controls Iron dextran Significant differences 
Desferrloxamlne Desferrioxamine 
Age Mean S® Mean S® Mean S® Mean S® A/B A/C A/D B/C B/D C/D 
(mn./hr.) (nm./hr.) (nm./hr.) (mm./hr.) 
b h _b „b A B C D 
1 wk. 4.8 3.2 5.2 3.4 1.8 1.8 1.2 1.2 * * * * 
2 wk. 17.3 11.0 18.1 9.4 1.9 1.8 1.1 0.8 * * * * 
3 wk. 16.3 3.7 16.2 5.7 2.5 6.3 0.5 0.8 * * * * 
4 wk. 13.1 6.9 14.5 5.1 0.2 0.5 0.8 0.7 * * * * 
5 wk. 13.1 8.1 12.0 4.3 0 0 1.1 1.1 * * * * * 
6 wk. 14.6 12.3 10.1 3.9 1.2 0.9 5.8 7.4 * * 
7 wk. 17.6 17.9 11.9 7.0 1.4 1.1 8.6 12.6 * 
8 wk. 19.7 20.2 25.5 25.3 2.4 2.1 8.6 8.4 * 
9 wk. 14.7 13.6 20.3 24.6 3.0 1.8 6.0 6.0 * 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 19b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparison 
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Effects of iron dextran and desferrioxamine on the sedi­
mentation rate of erythrocytes of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. * * * ** 
2 wk. *** *** *** *** 
3 wk. *** *** *** *** 
4 wk. *** *** *** *** 
5 wk. * *** * *** 
6 wk. * *** 
7 wk. * 
8 wk. * 
9 wk. * 
*P <[0.05 
**P <^0,01 
***P <(J).005 
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two and three weeks of age, while Kunesh found significant differences 
due to age. 
The more rapid rate of leukocyte production on the part of the iron 
treated pigs leads to the speculation that resistance to disease may in 
fact be more closely associated with this phenomenon than with the 
production of antibodies. 
Table 20a. Effects of iron dextran and desferrioxamlne on the number^ of leukocytes per 
cubic millimeter of blood of pigs 
Controls* Iron dextran* Significant differences^ 
Desferrioxamlne ^Deaferrloxamige 
Age Mean S Mean S Mean S Mean S A/B A/C A/D B/C B/D C/D 
(xl03) (xl03) (xl03) (xl03) 
1 wk. 8.1 1.7 8.6 1.7 10.5 3.5 10.8 2.9 * 
2 wk. 5.7 1.5 6,6 1.9 10.6 7.7 10.8 2.7 * * 
3 wk. 6.1 2.1 11.2 5.1 11.2 1.2 10.0 2.6 * * * 
4 wk. 10.5 3.2 8.2 2.6 11.5 4.4 12.7 3,1 * 
5 wk. 9,6 3.2 10.0 2.2 18.2 4.6 15.4 3.1 * * * * 
6 wk. 11.4 3.8 10.4 3.8 18.3 3.4 19.1 6,5 * * * * 
7 wk. 15.6 6.0 18.9 4.7 24.2 5.7 25.8 7,2 * * * * 
8 wk. 21.5 9.3 20.0 2.1 31.5 6.7 28.4 5.2 •k * * * 
9 wk. 22.6 6.5 22.4 5.2 26.0 3.5 26,1 4.0 
*n (number of observations) for each group at each age = 8 except for the nontreated 
control group where n = 7 
^Significant difference of the means as determined by the use of the least significant 
difference test (see Table 20b for degree of significance) 
^Standard deviation of the mean 
^Group designation for statistical comparisons 
^Corrected for nucleated red cells 
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Table 2Ub. Degree or signiricanc differences inùivaLeù lu lôulc 2Ca. 
Effects of iron dextran and desferrioxamine on the number 
of leukocytes; per cubic millimeter of blood of pigs 
Significant differences 
Age A/B A/C A/D B/C B/D C/D 
1 wk. * 
2 wk. *** *** 
3 wk. * *** ** 
4 wk. ** 
5 wk. *** *** *** *** 
6 wk. *** * ** ** 
7 wk. * ** * * 
8 wk. * *** *** 
9 wk. 
*P <^0.05 
**P <[^0.01 
***P <^.005 
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V. SUMMARY 
Comparisons of circulating antibody titers, urinary iron, serum 
iron, serum iron-binding capacity, residual iron binding capacity, as 
well as the classical hematologic values of leukocyte count, erythro­
cyte count, hemoglobin, packed cell volume, and erythrocyte sedimenta­
tion rate were made among iron-deficient control pigs, iron-deficient 
pigs which received desferrioxamine, iron-treated pigs which received 
intramuscular injections of iron dextran, and iron dextran treated pigs 
which subsequently received desferrioxamine. Desferrioxamine was 
studied to determine its efficacy as an iron chelating agent in the pig, 
and its toxicity at therapeutic dosage levels was studied. In addition, 
the Zeman (1966) cannula was modified and adapted for use on the young 
growing pigs, and the Zak and Epstein (1965) automated procedure for 
determining serum iron was modified for use in determining serum iron— 
binding capacity and urinary iron. 
The data collected in this study indicate that neither iron 
deficiency nor desferrioxamine had any effect on the pig's ability to 
produce antibodies, although anemic pigs, whether given desferrioxamine 
or not, appear to maintain a higher antibody titer over a longer period 
of time. 
Urinary iron excretion was found to be higher in the iron-treated 
pig than in nontreated controls. The average loss of iron in the urine 
of iron-treated pigs was 17.76 while that for littermate controls 
not receiving iron approximated 6.82 Desferrioxamine was shown to 
be very effective in increasing the urinary excretion of iron. In 
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itwii-i-Lcaucd pigs which cubccqucr.tly recei"®"^ Hecferrioxamine. the 
urinary iron excretion increased 10.5 times on the first day following 
treatment and gradually declined so that after 18 days the iron excre­
tion had fallen to approximately two times pre-treatment levels. 
Serum iron was shown to be significantly different between iron--
treated and control pigs. It was further shown that desferrioxamine 
would decrease serum iron of either iron-treated or control pigs so that 
after 17 days of treatment with desferrioxamine, significant differences 
in serum iron existed between iron-treated pigs and iron-treated pigs 
which subsequently received desferrioxamine. Furthermore, desferriox­
amine produced significant differences in serum iron between anemic 
control pigs and anemic pigs which were treated with desferrioxamine. 
•fliis further shows that desferrioxamine is effective in removing iron 
from the body of the pig. 
Serum iron-binding capacity was shown to be significantly higher 
in pigs having iron-deficiency anemia than in those pigs which were 
treated with iron dextran. This is in contradiction with previous 
reports on this subject in wine. Again, desferrioxamine, in lowering 
the serum iron, caused an increase in iron-binding capacity so that 
significant differences between anemic controls and pigs receiving iron 
dextran followed by desferrioxamine are not seen from the sixth week 
until the study was terminated at ten weeks. 
Levels of residual Iron binding capacity were found to be signif­
icantly higher in anemic than in iron-treated pigs. Desferrioxamine, by 
chelating iron, caused an increase in transferrin production so that 
significant differences can be seen in all groups studied after 
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deeferrinxamine had been administered for 17 davs. This difference was 
shown to persist in iron-treated pigs from the fifth to the ninth week 
of the study. 
Data obtained for erythrocyte count, hemoglobin, packed cell 
volume, and erythrocyte sedimentation rate were shown to be significantly 
different for iron-treated and control groups. The values for the iron--
treated pigs were consistently higher than those seen in the anemic 
controls except for the sedimentation rate. The administration of 
desferrioxamlne altered the values obtained in such a manner that 
significant differences in sedimentation rates were lost between anemic 
and iron-dextran, desferrioxamine treated pigs after 17 days. Packed 
cell volume, erythrocyte number, and hemoglobin content were shown to be 
significantly different from iron-dextran treated pigs at this time. 
Clinical observations and histological study of tissues collected 
from pigs given therapeutic dosage levels of desferrioxamine show that 
desferrioxamine is quite nontoxic in the young pig. Figs used for this 
study ranged from 18 to 36 days of age, and no toxicity symptoms or 
lesions were observed. 
Total urine excretion was measured to determine the total amount 
of iron lost in the urine each day. It was found that pigs ranging from 
11 to 36 days of age excrete approximately 560 ml. of urine during a 
24-hour period. 
Body weights were taken once weekly on all pigs used in the study. 
Significant differences in body weight were shown between iron-deficient 
and iron-treated pigs; however, desferrioxamine treatment had no signif­
icant effect on body wei^t. 
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is not attributed to faulty antibody production based on equine ferritin 
as an antigen. This was revealed by measuring the circulating antibody 
titers following the administration of equine ferritin. No significant 
differences could be shown among anemic, anemic-desferrioxamine treated, 
iron-dextran treated, or iron-dextran, desferrioxamine treated groups. 
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